{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:31:31Z","timestamp":1792161091391,"version":"4.4.0"},"reference-count":89,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UF Health Cancer Center Postdoctoral Award","award":["U01CA275310"],"award-info":[{"award-number":["U01CA275310"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01CA275310"],"award-info":[{"award-number":["U01CA275310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children\u2019s Miracle Network","award":["U01CA275310"],"award-info":[{"award-number":["U01CA275310"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Recent studies have strengthened the evidence for Epstein\u2013Barr Virus (EBV) as an important contributing factor in the development of multiple sclerosis (MS). Chronic inflammation is a key feature of MS. EBV+ B cells can express cytokines and exosomes that promote inflammation, and EBV is known to be reactivated through the upregulation of cellular inflammasomes. Inflammation is a possible cause of the breakdown of the blood\u2013brain barrier (BBB), which allows the infiltration of lymphocytes into the central nervous system. Once resident, EBV+ or EBV-specific B cells could both plausibly exacerbate MS plaques through continued inflammatory processes, EBV reactivation, T cell exhaustion, and\/or molecular mimicry. Another virus, SARS-CoV-2, the cause of COVID-19, is known to elicit a strong inflammatory response in infected and immune cells. COVID-19 is also associated with EBV reactivation, particularly in severely ill patients. Following viral clearance, continued inflammation may be a contributor to post-acute sequelae of COVID-19 infection (PASC). Evidence of aberrant cytokine activation in patients with PASC supports this hypothesis. If unaddressed, long-term inflammation could put patients at risk for reactivation of EBV. Determining mechanisms by which viruses can cause inflammation and finding treatments for reducing that inflammation may help reduce the disease burden for patients suffering from PASC, MS, and EBV diseases.<\/jats:p>","DOI":"10.3390\/v15040949","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T03:49:17Z","timestamp":1681271357000},"page":"949","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Inflammation and Epstein\u2013Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection"],"prefix":"10.3390","volume":"15","author":[{"given":"Beth A.","family":"Rousseau","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-9497","authenticated-orcid":false,"given":"Sumita","family":"Bhaduri-McIntosh","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA"},{"name":"Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","article-title":"Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors","volume":"72","author":"Kerr","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.0000000000200243","article-title":"New Evidence for Epstein-Barr Virus Infection as a Cause of Multiple Sclerosis","volume":"98","author":"Hacohen","year":"2022","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00001648-200003000-00023","article-title":"Epstein-Barr Virus and Multiple Sclerosis","volume":"11","author":"Ascherio","year":"2000","journal-title":"Epidemiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein\u2013Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies","volume":"26","author":"Pender","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the epstein-barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1586\/ern.13.6","article-title":"Epstein\u2013Barr virus and multiple sclerosis: Association or causation?","volume":"13","author":"Pakpoor","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11910-021-01110-5","article-title":"Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications","volume":"21","author":"Simkins","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"757302","DOI":"10.3389\/fimmu.2021.757302","article-title":"Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis","volume":"12","author":"Meier","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Angelini, D.F., Serafini, B., Piras, E., Severa, M., Coccia, E.M., Rosicarelli, B., Ruggieri, S., Gasperini, C., Buttari, F., and Centonze, D. (2013). Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003220"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","article-title":"Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis","volume":"129","author":"Lunemann","year":"2006","journal-title":"Brain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1004","DOI":"10.1212\/NXI.0000000000001004","article-title":"Exosomes From Subjects With Multiple Sclerosis Express EBV-Derived Proteins and Activate Monocyte-Derived Macrophages","volume":"8","author":"Mrad","year":"2021","journal-title":"Neurol.-Neuroimmunol. Neuroinflamm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Soldan, S.S., Su, C., Lamontagne, R.J., Grams, N., Lu, F., Zhang, Y., Gesualdi, J.D., Frase, D.M., Tolvinski, L.E., and Martin, K. (2021). Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes. PLOS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009618"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1128\/JVI.75.8.3537-3546.2001","article-title":"Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection","volume":"75","author":"Spender","year":"2001","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bhaduri-McIntosh, S., and McIntosh, M. (2021). Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus. Viruses, 13.","DOI":"10.3390\/v13050846"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"Burton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479\u2013480","author":"Kahan","year":"2015","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-cell control of Epstein\u2013Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin. Transl. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular Mimicry and Autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular Mimicry as a Mechanism of Autoimmune Disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature06559","article-title":"Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets","volume":"451","author":"Han","year":"2008","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/d41586-022-00382-2","article-title":"Multiple sclerosis sparked by virus-led autoimmunity","volume":"603","author":"Wekerle","year":"2022","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e78200","DOI":"10.7554\/eLife.78200","article-title":"Post-acute sequelae of COVID-19: A metabolic perspective","volume":"11","author":"Scherer","year":"2022","journal-title":"eLife"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1007\/s00415-022-11141-8","article-title":"Post-COVID-19 fatigue: The contribution of cognitive and neuropsychiatric symptoms","volume":"269","author":"Calabria","year":"2022","journal-title":"J. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moldofsky, H., and Patcai, J. (2011). Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol., 11.","DOI":"10.1186\/1471-2377-11-37"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jcp.2009.071944","article-title":"A case of chronic fatigue syndrome triggered by influenza H1N1 (swine influenza)","volume":"63","author":"Vallings","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/M21-4905","article-title":"A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings","volume":"175","author":"Sneller","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e200003","DOI":"10.1212\/NXI.0000000000200003","article-title":"Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection","volume":"9","author":"Peluso","year":"2022","journal-title":"Neurol.-Neuroimmunol. Neuroinflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Willscher","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jmii.2022.09.001","article-title":"Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery","volume":"55","author":"Ruenjaiman","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2215\/CJN.07590714","article-title":"Cytokines: Names and Numbers You Should Care About","volume":"10","author":"Holdsworth","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jleuko\/qiac001","article-title":"Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: Review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID","volume":"113","author":"Islam","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From Clinical Significance to Quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"746021","DOI":"10.3389\/fimmu.2021.746021","article-title":"Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection","volume":"12","author":"Patterson","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e28364","DOI":"10.1002\/jmv.28364","article-title":"Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19","volume":"95","author":"Willscher","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yin, K., Peluso, M.J., Thomas, R., Shin, M.-G., Neidleman, J., Luo, X., Hoh, R., Anglin, K., Huang, B., and Argueta, U. (2023). Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv.","DOI":"10.1101\/2023.02.09.527892"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Swank, Z., Senussi, Y., Alter, G., and Walt, D.R. (2022). Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Medrxiv.","DOI":"10.1101\/2022.06.14.22276401"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"949787","DOI":"10.3389\/fimmu.2022.949787","article-title":"Saliva antibody-fingerprint of reactivated latent viruses after mild\/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Apostolou","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E383","DOI":"10.1148\/radiol.2021211396","article-title":"CT of Post-Acute Lung Complications of COVID-19","volume":"301","author":"Solomon","year":"2021","journal-title":"Radiology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jcsm.12896","article-title":"Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19","volume":"13","author":"Soares","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104913","DOI":"10.1016\/j.micinf.2021.104913","article-title":"NLRP3 inflammasome activation in COVID-19: An interlink between risk factors and disease severity","volume":"24","author":"Amin","year":"2022","journal-title":"Microbes Infect."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2017.10.011","article-title":"Recent advances in inflammasome biology","volume":"50","author":"Place","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2102975118","DOI":"10.1073\/pnas.2102975118","article-title":"Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration","volume":"118","author":"Ambati","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.18071\/isz.74.0389","article-title":"Fluoxetine use is associated with improved survival of patients with COVID-19 pneumonia: A retrospective case-control study","volume":"74","author":"Vitrai","year":"2021","journal-title":"Ideggy\u00f3gy. Szle."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"630479","DOI":"10.3389\/fcell.2021.630479","article-title":"Targeting the NLRP3 Inflammasome via BTK","volume":"9","author":"Weber","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","article-title":"Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation","volume":"54","author":"Xian","year":"2021","journal-title":"Immunity"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103803","DOI":"10.1016\/j.ebiom.2021.103803","article-title":"Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice","volume":"75","author":"Zeng","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","article-title":"Positive Epstein\u2013Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Gold, J.E., Okyay, R.A., Licht, W.E., and Hurley, D.J. (2021). Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens, 10.","DOI":"10.3390\/pathogens10060763"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Klein, J., Wood, J., Jaycox, J., Lu, P., Dhodapkar, R.M., Gehlhausen, J.R., Tabachnikova, A., Tabacof, L., Malik, A.A., and Kamath, K. (2022). Distinguishing features of Long COVID identified through immune profiling; Infectious Diseases (except HIV\/AIDS). Medrxiv.","DOI":"10.1101\/2022.08.09.22278592"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cui, J., Yan, W., Xu, S., Wang, Q., Zhang, W., Liu, W., and Ni, A. (2018). Anti-Epstein\u2013Barr virus antibodies in Beijing during 2013\u20132017: What we have found in the different patients. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193171"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kongsomros, S., Thanunchai, M., Manopwisedjaroen, S., Na-Ek, P., Wang, S.-F., Taechalertpaisarn, T., and Thitithanyanont, A. (2020). Trogocytosis with monocytes associated with increased \u03b12,3 sialic acid expression on B cells during H5N1 influenza virus infection. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239488"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"632290","DOI":"10.3389\/fmolb.2021.632290","article-title":"Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection","volume":"8","author":"Barberis","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e00192-21","DOI":"10.1128\/JVI.00192-21","article-title":"Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells","volume":"95","author":"Verma","year":"2021","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1038\/s41380-022-01545-3","article-title":"Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists","volume":"27","author":"Khani","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-017-2753-2","article-title":"Partners in crime: Neutrophils and monocytes\/macrophages in inflammation and disease","volume":"371","author":"Nicholls","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"eabo5795","DOI":"10.1126\/scitranslmed.abo5795","article-title":"A persistent neutrophil-associated immune signature characterizes post\u2013COVID-19 pulmonary sequelae","volume":"14","author":"George","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ryan, F.J., Hope, C.M., Masavuli, M.G., Lynn, M.A., Mekonnen, Z.A., Yeow, A.E.L., Garcia-Valtanen, P., Al-Delfi, Z., Gummow, J., and Ferguson, C. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med., 20.","DOI":"10.1186\/s12916-021-02228-6"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"De Bondt, M., Hellings, N., Opdenakker, G., and Struyf, S. (2020). Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS). Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124558"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1352458515586084","article-title":"Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica","volume":"22","author":"Hertwig","year":"2016","journal-title":"Mult. Scler. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1080\/15548627.2022.2047343","article-title":"Targeting lipophagy in macrophages improves repair in multiple sclerosis","volume":"18","author":"Haidar","year":"2022","journal-title":"Autophagy"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000357780","article-title":"The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis","volume":"21","author":"Vazirinejad","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnen\/nlx114","article-title":"To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis","volume":"77","author":"Berneman","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Littlefield, K.M., Watson, R.O., Schneider, J.M., Neff, C.P., Yamada, E., Zhang, M., Campbell, T.B., Falta, M.T., Jolley, S.E., and Fontenot, A.P. (2022). SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLOS Pathog., 18.","DOI":"10.1101\/2022.02.14.480317"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/vim.2019.0207","article-title":"B Cell Activation and Response Regulation During Viral Infections","volume":"33","author":"Lam","year":"2020","journal-title":"Viral Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.medj.2020.12.001","article-title":"Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation","volume":"1","author":"Zhang","year":"2020","journal-title":"Med"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14728222.2020.1709823","article-title":"\u2018Prototypical\u2019 pro-inflammatory cytokine (IL-1) in multiple sclerosis: Role in pathogenesis and therapeutic targeting","volume":"24","author":"Musella","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_88","unstructured":"Hooftman, A., Zotta, A., and O\u2019Neill, L.A.J. (2023). Inflammasome Biology, Elsevier."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"114919","DOI":"10.1016\/j.ejmech.2022.114919","article-title":"Development of novel oridonin analogs as specifically targeted NLRP3 inflammasome inhibitors for the treatment of dextran sulfate sodium-induced colitis","volume":"245","author":"Pang","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/4\/949\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:14:23Z","timestamp":1760123663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/4\/949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":89,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["v15040949"],"URL":"https:\/\/doi.org\/10.3390\/v15040949","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]}}}